scholarly article | Q13442814 |
P2093 | author name string | R H Begent | |
M K Boehm | |||
S J Perkins | |||
B J Sutton | |||
P A Keep | |||
J D Thornton | |||
M K Sohi | |||
T Wan | |||
A L Corper | |||
K A Chester | |||
P2860 | cites work | DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES | Q24679675 |
Improved methods for building protein models in electron density maps and the location of errors in these models | Q26776980 | ||
Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7-A resolution | Q27729374 | ||
Crystal structure of a diabody, a bivalent antibody fragment | Q27729940 | ||
A single chain Fv fragment of P-glycoprotein-specific monoclonal antibody C219. Design, expression, and crystal structure at 2.4 A resolution | Q27747537 | ||
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features | Q27860675 | ||
The interpretation of protein structures: Estimation of static accessibility | Q27860750 | ||
Solvent content of protein crystals | Q27860807 | ||
Standard conformations for the canonical structures of immunoglobulins | Q28254522 | ||
Conformation of Polypeptides and Proteins | Q29617878 | ||
Definition of general topological equivalence in protein structures. A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming | Q30405607 | ||
Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction. | Q30430828 | ||
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli | Q33638891 | ||
Anatomy of the antibody molecule | Q34060425 | ||
Structure, function and properties of antibody binding sites | Q35011078 | ||
An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity | Q36270017 | ||
A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridoma | Q36704446 | ||
Phage libraries for generation of clinically useful antibodies | Q36721393 | ||
Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library | Q36816741 | ||
Monoclonal antibodies in diagnosis and therapy | Q37755851 | ||
Antibody-antigen interactions: new structures and new conformational changes | Q40399620 | ||
Single-chain Fvs. | Q40569728 | ||
Structural features of the reactions between antibodies and protein antigens. | Q40569734 | ||
Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates | Q41082594 | ||
Conformational Similarity and Systematic Displacement of Complementarity Determining Region Loops in High Resolution Antibody X-ray Structures | Q42681987 | ||
Domain association in immunoglobulin molecules. The packing of variable domains | Q44715886 | ||
Conformations of the third hypervariable region in the VH domain of immunoglobulins | Q47626454 | ||
Extended glycoprotein structure of the seven domains in human carcinoembryonic antigen by X-ray and neutron solution scattering and an automated curve fitting procedure: implications for cellular adhesion | Q47629306 | ||
Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. | Q47700146 | ||
Protein volumes and hydration effects. The calculations of partial specific volumes, neutron scattering matchpoints and 280-nm absorption coefficients for proteins and glycoproteins from amino acid sequences. | Q52641055 | ||
Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex. | Q54636019 | ||
Identification of specificity-determining residues in antibodies | Q57985940 | ||
On the nature of antibody combining sites: Unusual structural features that may confer on these sites an enhanced capacity for binding ligands | Q67656994 | ||
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms | Q68141138 | ||
Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule | Q69579655 | ||
Structural patterns at residue positions 9, 18, 67 and 82 in the VH framework regions of human and murine immunoglobulins | Q70602546 | ||
Structural classification of CDR-H3 in antibodies | Q71937510 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
crystal structure | Q895901 | ||
P304 | page(s) | 519-28 | |
P577 | publication date | 2000-03-01 | |
P1433 | published in | Biochemical Journal | Q864221 |
P1476 | title | Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts | |
P478 | volume | 346 Pt 2 |
Q47138591 | ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy |
Q34575951 | Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties |
Q27655335 | Crystal Structure of a Fibroblast Growth Factor Homologous Factor (FHF) Defines a Conserved Surface on FHFs for Binding and Modulation of Voltage-gated Sodium Channels |
Q36141544 | Cytokinergic IgE Action in Mast Cell Activation |
Q33226563 | Dynamic force spectroscopy of parallel individual Mucin1-antibody bonds |
Q39957224 | Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus |
Q42000959 | Generation and characterization of monospecific and bispecific hexavalent trimerbodies |
Q37617137 | Imaging in targeted delivery of therapy to cancer |
Q35477596 | Mechanism of the antigen-independent cytokinergic SPE-7 IgE activation of human mast cells in vitro |
Q30393523 | Molecular Imaging of Pancreatic Cancer with Antibodies |
Q37366754 | Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors. |
Q43236564 | Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK. |
Q37207310 | Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen. |
Q42657377 | The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity |